Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 3—March 2026
Dispatch
Optimal Specimens and Lesions for Mpox Diagnosis Using Real-Time PCR, South Korea
Table 2
Comparison of the positive rate and Ct value of real-time PCR at the time point of each specimen after symptom onset in patients with mpox, South Korea, 2022–2023*
| Specimen type | Days since symptom onset |
χ2 | p value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0–1 |
2–3 |
4–10 |
10 |
||||||||||
| No. (%) positive | Median (IQR) Ct | No. (%) positive | Median (IQR) Ct | No. (%) positive | Median (IQR) Ct | No. (%) positive | Median (IQR) Ct | ||||||
| Skin lesion, n = 362 | 67/76 (88.2) | 27.38 (21.9–34.8) | 47/48 (97.9) | 21.41 (19.5–25.0) | 177/188 (94.2) | 21.7 (18.8–27.4) | 45/50 (90.0) | 20.18 (17.8–24.0) | 0.1421 | <0.0001 | |||
| Upper respiratory tract, n = 109 | 18/24 (75.0) |
33.47 (28.2–39.2) | 10/15 (66.7) |
34.34 (30.5–40.0) | 37/57 (64.9) | 33.9 (29.2–40.0) | 10/13 (76.9) | 30.98 (25.0–37.2) | 0.7380 | 0.3689 | |||
| Blood, n = 135 | 8/25 (32.0) |
40 (36.9–40) | 8/22 (36.4) | 40 (38.0–40) | 18/74 (24.3) | 40 (39.84–40) | 4/14 (28.6) | 40 (36.6–40) | 0.6930 | 0.7635 | |||
| Rectal swab, n = 6 | 1/1 (100) | 20.54 (20.5–20.5) | 2/2 (100) |
18.7 (17.6–19.8) | 1/1 (100) | 22.0 (22.0–22.0) | 2/2 (100) | 26.43 (22.0–30.8) | NA | 0.1778 | |||
*Denominators indicate no. specimens tested on those days. χ2 value is of positivity rate; p value is of Ct. Ct, cycle threshold; IQR, interquartile range; NA, not available.
Page created: February 13, 2026
Page updated: March 03, 2026
Page reviewed: March 03, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.